Stem Cell Therapy Market Overview
The stem cell therapy market is
poised for substantial growth between 2025 and 2035, fuelled by breakthroughs
in regenerative medicine and heightened investment in research and development.
Valued at approximately USD 8.1 billion in 2025, the market is projected to
surge to USD 18.6 billion by 2035, reflecting a compound annual growth rate
(CAGR) of 7.9% over the decade.
Stem cell therapy is a
cutting-edge regenerative medicine that uses stem cells to regenerate, replace,
or restore damaged tissues and organs. Stem cells are cells with self-renewal
and differentiation capabilities into various specialized cell types and are
used to treat various diseases and injuries. Sources of stem cells are
primarily embryonic stem cells (ESCs), adult stem cells (such as mesenchymal
stem cells in bone marrow and adipose tissues), and induced pluripotent stem
cells (iPSCs), reprogrammed adult cells with embryo-like properties.
One of the best-established
applications of stem cell therapy is for hematopoietic stem cell
transplantation (HSCT), also bone marrow transplantation, for treating blood
illnesses such as leukaemia, lymphoma, and sickle cell anaemia. Stem cell
therapy has been found to be effective in treating neurodegenerative illnesses
such as Parkinson’s and Alzheimer’s and in treating injury to the spinal cord
by replacing absent nerve cells and allowing neural regeneration. In cardiology
as well, stem cells are explored to regenerate cardiac tissue following
myocardial infarctions. Research and clinical trials continue to make these
treatments safer and more effective for application in medical practice. Stem
cell therapy is increasing and is offering hope to what were previously
incurable diseases.
Stem Cell Therapy Market Drivers and Opportunities
Advancements in Regenerative Medicine is anticipated to lift
the Stem Cell Therapy Market during the forecast period
Continuous development in
regenerative medicine is having a significant impact on the stem cell therapy
market. Researchers are developing sophisticated techniques such as induced
pluripotent stem cells (iPSCs) and gene editing tools such as CRISPR to make
stem cell therapy more efficient. Such developments offer personalized medicine
that improves patient recovery in conditions like neurodegenerative diseases,
cardiovascular disease, and orthopaedic trauma. Growing awareness of stem cell
biology and differentiation processes is making therapy safer and more specific
and is increasing investor and regulatory approval.
Rising Prevalence of Chronic Diseases for influencing the
growth of the global Stem Cell Therapy Market
The increase in rates of chronic
and degenerative diseases such as diabetes, cancer, and musculoskeletal disease
is fueling demand for stem cell therapy. With increasing global populations and
older age structures, there is increased demand for regenerative medicines that
go beyond traditional treatment. Stem cell-based therapy has disease-modifying
effects with long-term advantages. This demand encourages pharmaceutical and
biotech companies to invest in research to fuel faster commercialization of innovative
medicines.
Opportunity for the Stem Cell
Therapies Market
Expansion into Neurological
Disorders is poised to create significant opportunities in the global stem cell
therapy market
The highest potential for the stem
cell therapy market is in treating neurological diseases like Parkinson’s
disease, Alzheimer’s disease, and spinal cord injuries. Treatment for these
diseases is currently limited and symptomatic. Stem cell therapy can regenerate
damaged neurons and restore function. Clinical trials and support for
breakthrough drugs support this potential. If found to be effective, stem
cell-based neurological treatments would revolutionize health care and attract
significant investment by health care providers and biotech firms.
Stem Cell Therapy Market Scope
Report
Attributes |
Description |
Market Size in 2025 |
USD 8.1 Billion |
Market
Forecast in 2035 |
USD 18.6
Billion |
CAGR % 2025-2035 |
7.9% |
Base
Year |
2024 |
Historic Data |
2020-2024 |
Forecast
Period |
2025-2035 |
Report USP
|
Production, Consumption, company
share, company heatmap, company production capacity, growth factors and more |
Segments
Covered |
|
Regional Scope |
|
Country
Scope |
|
Stem Cell Therapy Market Report Segmentation Analysis
The global stem cell therapy
market industry analysis is segmented into by Type, by cell source, by
Application, by End-user, and by region.
The Allogeneic Stem Cell Therapy segment is anticipated to hold the
highest share of the global Stem Cell Therapy Market during the projected
timeframe.
The Allogeneic Stem Cell Therapy
segment is set to dominate the global Stem Cell Therapy Market through the
forecast period. This is driven by increasing demand for off-the-shelf stem
cell therapy that offers a standardized treatment in comparison to autologous
therapy. Allogeneic stem cell therapy employs donor cells and avoids
patient-invasive procedures and guarantees instant availability for serious
conditions.
The growing prevalence of chronic diseases like blood diseases, immune system disorders, and cancers has been a key factor in driving this sector. Additionally, advances in cell banking, donor compatibility, and immunosuppressive techniques have made allogeneic stem cell therapy safer and more efficient and have driven greater adoption.
The Mesenchymal Stem Cells (MSCs) segment is anticipated to hold the
highest share of the market over the forecast period.
On the basis of cell sources, the
market is bifurcated into Adult Stem Cells (ASCs), Hematopoietic Stem Cells
(HSCs), Mesenchymal Stem Cells (MSCs), Human Embryonic Stem Cells (HESCs) and
Induced Pluripotent Stem Cells (iPSCs). The Mesenchymal Stem Cells (MSCs)
segment is anticipated to hold the largest share of the Stem Cell Therapy
Market through the forecast period. MSCs with regenerative and immunomodulatory
properties are used extensively to cure degenerative diseases, immune-related
diseases, and inflammatory diseases. MSCs are capable of differentiating into
various cell types including bone cells, cartilage cells, and fat cells and are
hence of immense application in regenerative medicine.
The increasing application of
MSCs in orthopaedics, neurology, cardiology, and oncology has fuelled demand
for MSCs. Moreover, improvements in stem cell culture techniques and expansion
processes have improved scalability and affordability of MSC-based therapy.
Research centers and pharmaceutical companies are actively seeking new MSC
therapy applications, and this is leading to more clinical trials and
approvals. Demand for minimally invasive therapy and greater awareness of MSC
therapy benefits also fuel market adoption.
The Musculoskeletal Disorders segment dominated the market in 2024 and
is predicted to grow at the highest CAGR over the forecast period.
Application-wise, the Stem Cell
Therapy Market is segmented into Inflammatory & Autoimmune Disease,
Oncology, Cardiovascular Diseases, Wounds and Injuries, Haematology,
Musculoskeletal Disorders and Other Application. In 2024, the share of the
Musculoskeletal Disorders segment was the highest in the global Stem Cell
Therapy Market and is projected to grow with the highest compound annual growth
rate (CAGR) during the forecast period. Osteoarthritis, rheumatoid arthritis,
and spinal cord injuries are some of the musculoskeletal diseases that are
impacting millions of individuals around the world and are causing increasing
demand for regenerative medicine. Stem cell therapy is a possible replacement
for existing treatments by causing regeneration of tissues, reducing
inflammation and enhancing mobility. Rising age-related musculoskeletal
diseases and sports injuries have been a key factor in driving this segment.
Moreover, increased clinical trials and government support for studies on stem
cells are fueling the development of innovative treatments.
The Hospitals and speciality clinics segment are predicted to grow at the highest CAGR over the forecast period.
According to End-user, stem cell
therapy market is classified into Hospitals & Specialty Clinics The Pharma
and Biotech Companies, Research and Academic Organizations. Hospitals and
Specialty Clinics segment is projected to grow with the highest compound annual
growth rate (CAGR) in Stem Cell Therapy Market through the forecast period.
Expansion in stem cell treatment adoption in specialist and hospital clinics is
driven by rising patient demand for cutting-edge regenerative therapy and
improvement in healthcare infrastructure.
Hospitals and medical centers are
increasingly using stem cell therapy as part of routine medical practice to
address diseases such as musculoskeletal disease, cardiovascular disease,
neurological disease, and immune system dysfunctions. Specialized equipment and
skilled medical personnel make stem cell therapy more effective and are driving
the development of this segment. In addition, collaborations between medical
providers and biotech firms have given rise to stem cell therapy centers in
medical centers.
The following segments are part of an in-depth analysis of the global stem cell therapy market:
Market
Segments |
|
By Type |
|
By Cell Source |
|
By Application |
|
By End-user |
|
Stem Cell Therapy Market Share Analysis by Region
North America is
projected to hold the largest share of the global Stem Cell Therapy Market over
the forecast period.
The North American market is
expected to dominate the market for stem cell therapy across the forecast
period. This is attributed to several key factors that include advanced medical
infrastructure, strong research and development (R&D) practices, and
significant government and private investment in regenerative medicine. Strong
presence of top-class biotech companies, academic institutions, and research
centers also drives innovation and stem cell therapy commercialization in this
region. In March 2021, there were 1,480 U.S. businesses operating 2,754 clinics
that were marketing purported stem cell treatments for a range of indications.
More than four times more businesses than were operating 5 years ago are
marketing stem cell products that are not FDA-approved and lack compelling
proof of safety and efficacy.
The United States is of
particular significance for market development owing to having a strongly
established regulatory framework, increasing clinical trials, and increasing
application of stem cell-based therapy for conditions like neurological diseases,
cardiovascular disease, and orthopaedic disease. Rising rates of chronic
disease and increasing numbers of older individuals have also driven demand for
regenerative therapy.
Besides this, collaborations
between key stakeholders, support by the FDA through regulation, and funding by
organizations such as the National Institutes of Health (NIH) have also
expedited development and implementation of stem cell therapy in North America.
With continued progress in stem cell science, personalized medicine, and tissue
engineering, it is projected that the region will remain a global market
leader..
Stem Cell Therapy Market Competition Landscape Analysis
The market is competitive, with
several established players and new entrants offering a range of stem cell therapy
products. Some of the key players include Allogene Therapeutics, ANTEROGEN.CO.,
LTD. Atara Biotherapeutics, Bluebird bio, Inc., Cleveland Cord Blood Center,
CorestemChemon Inc., CRISPR Therapeutics.
Global Stem Cell
Therapy Market Recent Developments News:
o In
March of 2025, Cellino and Matricelf collaborated to drive personalized
treatments for spinal cord injury on a worldwide stage. By integrating
Cellino’s Nebula™ platform, an AI-powered biomanufacturing platform for iPSCs,
with Matricelf’s double autologous methodology for 3D differentiation, the
partnership is enabling scalable patient-customized treatments.
o Ginkgo
Bioworks is collaborating with Universal Cells (a subsidiary of Astellas) in
January of 2025 to maximize cancer treatments based on iPSC. Its cutting-edge
platforms for screening and engineering are designed to improve immune cell
therapy persistence and activity for solid tumors with emphasis on CAR-T cell
therapy and other immune-engineered cells
o Bristol Myers Squibb and Century Therapeutics formed a strategic partnership in September 2022 to advance therapy with allogeneic cells that are produced from induced pluripotent stem cells. Through this partnership, Century brings its cutting-edge iPSC-derived allogeneic cell therapy platform to combine with Bristol Myers Squibb's rich oncology drug development and cell therapy know-how.
The Global Stem Cell Therapy Market
is dominated by a few large companies, such as
·
Allogene Therapeutics
·
ANTEROGEN.CO., LTD.
·
Atara Biotherapeutics
·
Bluebird bio, Inc.
·
Cleveland Cord Blood Center
·
CorestemChemon Inc.
·
CRISPR Therapeutics
·
Gamida Cell
·
Highbridge Capital Management
·
Holostem S.r.l.
·
Intellia Therapeutics
·
Kyowa Kirin
·
Mesoblast Limited
·
STEMCELL Technologies Inc.
·
Vertex Pharmaceuticals, Inc..
·
Others
1. Global
Stem Cell Therapy Market Introduction and Market Overview
1.1.
Objectives of the Study
1.2.
Global Stem Cell Therapy Market Scope
and Market Estimation
1.2.1.Global Dental
Campsites Overall Market Size (US$ Bn), Market CAGR (%), Market forecast (2025
- 2035)
1.2.2.Global Stem
Cell Therapy Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2021 - 2035
1.3.
Market Segmentation
1.3.1.Type of
Global Stem Cell Therapy Market
1.3.2.Cell
Source of Global Stem Cell Therapy Market
1.3.3.Application
of Global Stem Cell Therapy Market
1.3.4.End-user
of Global Stem Cell Therapy Market
1.3.5.Region of
Global Stem Cell Therapy Market
2. Executive Summary
2.1.
Demand Side Trends
2.2.
Key Market Trends
2.3.
Market Demand (US$ Bn) Analysis 2021 –
2024 and Forecast, 2025 – 2035
2.4.
Demand and Opportunity Assessment
2.5.
Demand Supply Scenario
2.6.
Market Dynamics
2.6.1.Drivers
2.6.2.Limitations
2.6.3.Opportunities
2.6.4.Impact
Analysis of Drivers and Restraints
2.7.
Recent Progress of Stem Cell Therapy
in Cancer Treatment
2.8.
Key Products/Brand Analysis
2.9.
Porter’s Five Forces Analysis
2.9.1.Bargaining
Power of Suppliers
2.9.2.Bargaining
Power of Buyers
2.9.3.Threat of
Substitutes
2.9.4.Threat of
New Entrants
2.9.5.Competitive
Rivalry
2.10. PEST
Analysis
2.10.1.
Political Factors
2.10.2.
Economic Factors
2.10.3.
Social Factors
2.10.4.
Technology Factors
2.11. Key
Regulation
3. Global Stem Cell Therapy Market Estimates &
Historical Trend Analysis (2021 - 2024)
4.
Global
Stem Cell Therapy Market Estimates & Forecast Trend Analysis, by Type
4.1.
Global Stem Cell Therapy Market
Revenue (US$ Bn) Estimates and Forecasts, by Type, 2021 - 2035
4.1.1.Allogeneic
Stem Cell Therapy
4.1.2.Autologous
Stem Cell Therapy
5.
Global
Stem Cell Therapy Market Estimates & Forecast Trend Analysis, by Cell Source
5.1.
Global Stem Cell Therapy Market
Revenue (US$ Bn) Estimates and Forecasts, by Cell Source, 2021 - 2035
5.1.1.Adult Stem
Cells (ASCs)
5.1.2.Hematopoietic
Stem Cells (HSCs)
5.1.3.Mesenchymal
Stem Cells (MSCs)
5.1.4.Human
Embryonic Stem Cells (HESCs)
5.1.5.Induced
Pluripotent Stem Cells (iPSCs)
6.
Global
Stem Cell Therapy Market Estimates & Forecast Trend Analysis, by Application
6.1.
Global Stem Cell Therapy Market
Revenue (US$ Bn) Estimates and Forecasts, by Application, 2021 - 2035
6.1.1.Musculoskeletal
Disorders
6.1.2.Inflammatory
& Autoimmune Disease
6.1.3.Oncology
6.1.4.Cardiovascular
Diseases
6.1.5.Wounds and
Injuries
6.1.6.Hematology
6.1.7.Neurological
Disorders
6.1.8.Other
Application
7.
Global
Stem Cell Therapy Market Estimates & Forecast Trend Analysis, by End-user
7.1.
Global Stem Cell Therapy Market
Revenue (US$ Bn) Estimates and Forecasts, by End-user, 2021 - 2035
7.1.1.Hospitals
& Specialty Clinics
7.1.2.Pharmaceutical
and Biotechnology Companies
7.1.3.Academic
& Research Institutes
Global Stem Cell Therapy Market Estimates &
Forecast Trend Analysis,
by region
7.2.
Global Stem Cell Therapy Market
Revenue (US$ Bn) Estimates and Forecasts, by region, 2021 - 2035
7.2.1.North
America
7.2.2.Eastern Europe
7.2.3.Western
Europe
7.2.4.Asia
Pacific
7.2.5.Middle East
& Africa
7.2.6.Latin
America
8. North
America Stem Cell
Therapy Market: Estimates &
Forecast Trend Analysis
8.1. North
America Stem Cell Therapy Market Assessments & Key Findings
8.1.1.North
America Stem Cell Therapy Market Introduction
8.1.2.North
America Stem Cell Therapy Market Size Estimates and Forecast (US$ Billion) (2021
- 2035)
8.1.2.1.
By Type
8.1.2.2.
By Cell Source
8.1.2.3.
By Application
8.1.2.4.
By End-user
8.1.2.5.
By Country
8.1.2.5.1.
The U.S.
8.1.2.5.2.
Canada
8.1.2.5.3.
Mexico
9. Western
Europe Stem Cell
Therapy Market: Estimates &
Forecast Trend Analysis
9.1.
Western Europe Stem Cell Therapy
Market Assessments & Key Findings
9.1.1.Western Europe
Stem Cell Therapy Market Introduction
9.1.2.Western Europe
Stem Cell Therapy Market Size Estimates and Forecast (US$ Billion) (2021 - 2035)
9.1.2.1.
By Type
9.1.2.2.
By Cell Source
9.1.2.3.
By Application
9.1.2.4.
By End-user
9.1.2.5.
By Country
9.1.2.5.1. Germany
9.1.2.5.2. Italy
9.1.2.5.3. U.K.
9.1.2.5.4. France
9.1.2.5.5. Spain
9.1.2.5.6. Benelux
9.1.2.5.7. Nordics
9.1.2.5.8.
Rest
of W. Europe
10. Eastern
Europe Stem Cell
Therapy Market: Estimates &
Forecast Trend Analysis
10.1. Eastern
Europe Stem Cell Therapy Market Assessments & Key Findings
10.1.1.
Eastern Europe Stem Cell Therapy
Market Introduction
10.1.2.
Eastern Europe Stem Cell Therapy
Market Size Estimates and Forecast (US$ Billion) (2021 - 2035)
10.1.2.1.
By Type
10.1.2.2.
By Cell Source
10.1.2.3.
By Application
10.1.2.4.
By End-user
10.1.2.5.
By Country
10.1.2.5.1. Russia
10.1.2.5.2. Hungary
10.1.2.5.3. Poland
10.1.2.5.4. Balkan & Baltics
10.1.2.5.5. Rest of E. Europe
11. Asia
Pacific Stem Cell Therapy
Market: Estimates & Forecast Trend
Analysis
11.1. Asia
Pacific Market Assessments & Key Findings
11.1.1.
Asia Pacific Stem Cell Therapy Market
Introduction
11.1.2.
Asia Pacific Stem Cell Therapy Market
Size Estimates and Forecast (US$ Billion) (2021 - 2035)
11.1.2.1.
By Type
11.1.2.2.
By Cell Source
11.1.2.3.
By Application
11.1.2.4.
By End-user
11.1.2.5.
By Country
11.1.2.5.1.
China
11.1.2.5.2.
Japan
11.1.2.5.3.
India
11.1.2.5.4.
Australia & New Zealand
11.1.2.5.5.
South Korea
11.1.2.5.6.
ASEAN
11.1.2.5.7. Rest
of Asia Pacific
12. Middle
East & Africa Stem
Cell Therapy Market: Estimates &
Forecast Trend Analysis
12.1. Middle
East & Africa Market Assessments & Key Findings
12.1.1.
Middle East
& Africa Stem Cell Therapy Market Introduction
12.1.2.
Middle East
& Africa Stem Cell Therapy Market Size Estimates and
Forecast (US$ Billion) (2021 - 2035)
12.1.2.1.
By Type
12.1.2.2.
By Cell Source
12.1.2.3.
By Application
12.1.2.4.
By End-user
12.1.2.5.
By Country
12.1.2.5.1.
UAE
12.1.2.5.2.
Saudi Arabia
12.1.2.5.3.
Turkey
12.1.2.5.4.
South Africa
12.1.2.5.5. Rest of MEA
13. Latin
America Stem Cell
Therapy Market: Estimates &
Forecast Trend Analysis
13.1. Latin
America Market Assessments & Key Findings
13.1.1.
Latin America Stem Cell Therapy Market
Introduction
13.1.2.
Latin America Stem Cell Therapy Market
Size Estimates and Forecast (US$ Billion) (2021 - 2035)
13.1.2.1.
By Type
13.1.2.2.
By Cell Source
13.1.2.3.
By Application
13.1.2.4.
By End-user
13.1.2.5.
By Country
13.1.2.5.1.
Brazil
13.1.2.5.2.
Argentina
13.1.2.5.3.
Colombia
13.1.2.5.4. Rest of LATAM
14. Country
Wise Market: Introduction
15.
Competition Landscape
15.1. Global
Stem Cell Therapy Market Type Mapping
15.2. Global
Stem Cell Therapy Market Concentration Analysis, by Leading Players /
Innovators / Emerging Players / New Entrants
15.3. Global
Stem Cell Therapy Market Tier Structure Analysis
15.4. Global
Stem Cell Therapy Market Concentration & Company Market Shares (%)
Analysis, 2023
16.
Company Profiles
16.1.
Allogene Therapeutics
16.1.1.
Company Overview & Key Stats
16.1.2.
Financial Performance & KPIs
16.1.3.
Type Portfolio
16.1.4.
SWOT Analysis
16.1.5.
Business Strategy & Recent
Developments
*
Similar details would be provided for all the players mentioned below
16.2.
ANTEROGEN.CO., LTD.
16.3.
Atara Biotherapeutics
16.4.
Bluebird bio, Inc.
16.5.
Cleveland Cord Blood
Center
16.6.
CorestemChemon Inc.
16.7.
CRISPR Therapeutics
16.8.
Gamida Cell
16.9.
Highbridge Capital
Management
16.10.
Holostem S.r.l.
16.11.
Intellia Therapeutics
16.12.
Kyowa Kirin
16.13.
Mesoblast Limited
16.14.
STEMCELL Technologies
Inc.
16.15.
Vertex Pharmaceuticals, Inc.
16.16.
Other Prominent
Players
17. Research Methodology
17.1. External
Transportations / Databases
17.2. Internal
Proprietary Database
17.3. Primary
Research
17.4. Secondary
Research
17.5. Assumptions
17.6. Limitations
17.7. Report
FAQs
18. Research Findings & Conclusion
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Stem Cell Therapy Market was valued at USD 8.1 Billion in 2025.
Stem Cell Therapy Market size will increase at approximate CAGR of 7.9% during the forecasted period.
Major companies operating within the market are Allogene Therapeutics, ANTEROGEN.CO., LTD. Atara Biotherapeutics, Bluebird bio, Inc., Cleveland Cord Blood Center, CorestemChemon Inc., CRISPR Therapeutics and others.
North America dominates the stem cell therapy market over the forecasting period.
Only Three Thousand Four Hundred Ninety Nine US dollar
Only Four Thousand Four Hundred Ninety Nine US dollar
Only Five Thousand Four Hundred Ninety Nine US dollar